These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 32130359)

  • 1. Azithromycin administered for acute bronchiolitis may have a protective effect on subsequent wheezing.
    Luisi F; Roza CA; Silveira VD; Machado CC; Rosa KMD; Pitrez PM; Jones MH; Stein RT; Leitão LAA; Comaru T; Mocellin M; Pinto LA
    J Bras Pneumol; 2020; 46(3):e20180376. PubMed ID: 32130359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized trial to evaluate azithromycin's effects on serum and upper airway IL-8 levels and recurrent wheezing in infants with respiratory syncytial virus bronchiolitis.
    Beigelman A; Isaacson-Schmid M; Sajol G; Baty J; Rodriguez OM; Leege E; Lyons K; Schweiger TL; Zheng J; Schechtman KB; Castro M; Bacharier LB
    J Allergy Clin Immunol; 2015 May; 135(5):1171-8.e1. PubMed ID: 25458910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Azithromycin for acute bronchiolitis and wheezing episodes in children - a systematic review with meta-analysis.
    Ukkonen RM; Renko M; Kuitunen I
    Pediatr Res; 2024 May; 95(6):1441-1447. PubMed ID: 38066246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Azithromycin therapy in infants hospitalized for respiratory syncytial virus bronchiolitis: Airway matrix metalloproteinase-9 levels and subsequent recurrent wheeze.
    Beigelman A; Goss CW; Wang J; Srinivasan M; Boomer J; Zhou Y; Bram S; Casper TJ; Coverstone AM; Kanchongkittiphon W; Kuklinski C; Storch GA; Schechtman KB; Castro M; Bacharier LB
    Ann Allergy Asthma Immunol; 2024 May; 132(5):623-629. PubMed ID: 38237675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The azithromycin to prevent wheezing following severe RSV bronchiolitis-II clinical trial: Rationale, study design, methods, and characteristics of study population.
    Srinivasan M; Bacharier LB; Goss CW; Zhou Y; Boomer J; Bram S; Burgdorf D; Burnham CA; Casper T; Castro M; Coverstone A; Haslam M; Kanchongkittiphon W; Kuklinski C; Lian Q; Schechtman K; Storch GA; True K; Wallace MA; Yin-DeClue H; Ahrens E; Wang J; Beigelman A
    Contemp Clin Trials Commun; 2021 Jun; 22():100798. PubMed ID: 34189338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Azithromycin therapy in hospitalized infants with acute bronchiolitis is not associated with better clinical outcomes: a randomized, double-blinded, and placebo-controlled clinical trial.
    Pinto LA; Pitrez PM; Luisi F; de Mello PP; Gerhardt M; Ferlini R; Barbosa DC; Daros I; Jones MH; Stein RT; Marostica PJ
    J Pediatr; 2012 Dec; 161(6):1104-8. PubMed ID: 22748516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized placebo-controlled trial on azithromycin to reduce the morbidity of bronchiolitis in Indigenous Australian infants: rationale and protocol.
    Chang AB; Grimwood K; White AV; Maclennan C; Sloots TP; Sive A; McCallum GB; Mackay IM; Morris PS
    Trials; 2011 Apr; 12():94. PubMed ID: 21492416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of preschool children presenting to the emergency department with wheeze with azithromycin: A placebo-controlled randomized trial.
    Mandhane PJ; Paredes Zambrano de Silbernagel P; Aung YN; Williamson J; Lee BE; Spier S; Noseworthy M; Craig WR; Johnson DW
    PLoS One; 2017; 12(8):e0182411. PubMed ID: 28771627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum bilirubin is associated with a reduced risk of subsequent recurrent wheezing following acute respiratory syncytial virus bronchiolitis.
    Zhang X; Zhang X; Xu H; Tang X; Zhao S; Yang H
    Pediatr Pulmonol; 2023 Aug; 58(8):2333-2339. PubMed ID: 37222307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for recurrent wheezing following acute bronchiolitis: a 12-month follow-up.
    Cifuentes L; Caussade S; Villagrán C; Darrigrande P; Bedregal P; Valdivia G; Sánchez I
    Pediatr Pulmonol; 2003 Oct; 36(4):316-21. PubMed ID: 12950045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term effects of prednisolone in the acute phase of bronchiolitis caused by respiratory syncytial virus.
    van Woensel JB; Kimpen JL; Sprikkelman AB; Ouwehand A; van Aalderen WM
    Pediatr Pulmonol; 2000 Aug; 30(2):92-6. PubMed ID: 10922130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dexamethasone does not reduce length of hospitalization or recurrent wheezing 1 year after early bronchiolitis.
    Tagarro A; Pérez L; Quintero VM; Cañete A
    Minerva Pediatr; 2014 Apr; 66(2):131-40. PubMed ID: 24835446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhaled corticosteroids during acute bronchiolitis in the prevention of post-bronchiolitic wheezing.
    Blom D; Ermers M; Bont L; van Aalderen WM; van Woensel JB
    Cochrane Database Syst Rev; 2007 Jan; (1):CD004881. PubMed ID: 17253528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrent wheezing after respiratory syncytial virus or non-respiratory syncytial virus bronchiolitis in infancy: a 3-year follow-up.
    Valkonen H; Waris M; Ruohola A; Ruuskanen O; Heikkinen T
    Allergy; 2009 Sep; 64(9):1359-65. PubMed ID: 19416146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic review of montelukast's efficacy for preventing post-bronchiolitis wheezing.
    Peng WS; Chen X; Yang XY; Liu EM
    Pediatr Allergy Immunol; 2014 Mar; 25(2):143-50. PubMed ID: 24118637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired tumor necrosis factor-α secretion by CD4 T cells during respiratory syncytial virus bronchiolitis associated with recurrent wheeze.
    Kitcharoensakkul M; Bacharier LB; Yin-Declue H; Boomer JS; Sajol G; Leung MK; Wilson B; Schechtman KB; Atkinson JP; Green JM; Castro M
    Immun Inflamm Dis; 2020 Mar; 8(1):30-39. PubMed ID: 31901157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of Respiratory Syncytial Virus or Rhinovirus Weeks After Hospitalization for Bronchiolitis and the Risk of Recurrent Wheezing.
    Mansbach JM; Geller RJ; Hasegawa K; Piedra PA; Avadhanula V; Gern JE; Bochkov YA; Espinola JA; Sullivan AF; Camargo CA
    J Infect Dis; 2021 Feb; 223(2):268-277. PubMed ID: 32564083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Airway microbiome, host immune response and recurrent wheezing in infants with severe respiratory syncytial virus bronchiolitis.
    Zhang X; Zhang X; Zhang N; Wang X; Sun L; Chen N; Zhao S; He Q
    Pediatr Allergy Immunol; 2020 Apr; 31(3):281-289. PubMed ID: 31788862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for bronchiolitis, recurrent wheezing, and related hospitalization in preterm infants during the first year of life.
    Pérez-Yarza EG; Moreno-Galdó A; Ramilo O; Rubí T; Escribano A; Torres A; Sardón O; Oliva C; Pérez G; Cortell I; Rovira-Amigo S; Pastor-Vivero MD; Pérez-Frías J; Velasco V; Torres-Borrego J; Figuerola J; Barrio MI; García-Hernández G; Mejías A;
    Pediatr Allergy Immunol; 2015 Dec; 26(8):797-804. PubMed ID: 26031206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rhinovirus-associated wheezing in infancy: comparison with respiratory syncytial virus bronchiolitis.
    Korppi M; Kotaniemi-Syrjänen A; Waris M; Vainionpää R; Reijonen TM
    Pediatr Infect Dis J; 2004 Nov; 23(11):995-9. PubMed ID: 15545853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.